Advertisement
UK markets closed
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • CRUDE OIL

    83.00
    +1.65 (+2.03%)
     
  • GOLD FUTURES

    2,239.70
    +27.00 (+1.22%)
     
  • DOW

    39,815.17
    +55.09 (+0.14%)
     
  • Bitcoin GBP

    56,130.22
    +1,765.38 (+3.25%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • NASDAQ Composite

    16,385.91
    -13.62 (-0.08%)
     
  • UK FTSE All Share

    4,338.05
    +12.12 (+0.28%)
     

Better Big Biotech Buy: Biogen vs. Vertex

Better Big Biotech Buy: Biogen vs. Vertex

Two great examples are Biogen (NASDAQ: BIIB) and Vertex Pharmaceuticals (NASDAQ: VRTX). Biogen is known for its blockbuster multiple sclerosis drugs, including top seller Tecfidera. Biogen's immunology drug, Rituxan, has also seen sales slip due to biosimilars in the market.